David Lorente
Impact in
- Cancer Research top 1%
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 63
- Prostate Cancer Diagnosis and Treatment 11
- Oncology 47
- PARP inhibition in cancer therapy 12
- Cancer Treatment and Pharmacology 9
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Johann S. de Bono (50 shared papers)Aurelius Omlin (18 shared papers)Gerhardt Attard (20 shared papers)Joaquı́n Mateo (22 shared papers)Roberta Ferraldeschi (16 shared papers)Diletta Bianchini (24 shared papers)David Olmos (24 shared papers)Carmel Pezaro (11 shared papers)
- Journals
- Journal of Clinical Oncology (24 papers)Annals of Oncology (18 papers)European Urology (8 papers)British Journal of Cancer (6 papers)European Journal of Cancer (5 papers)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
David Lorente
94 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 102
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 1.8k
- Oncology 1.2k
- Radiology, Nuclear Medicine and Imaging 653
- Hematology 200
Countries citing papers authored by David Lorente
This map shows the geographic impact of David Lorente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lorente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lorente more than expected).
Fields of papers citing papers by David Lorente
This network shows the impact of papers produced by David Lorente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lorente. The network helps show where David Lorente may publish in the future.
Co-authors
The 25 scholars most cited alongside David Lorente, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 254 | |
| 2 | 2017 | 221 | |
| 3 | 2014 | 169 | |
| 4 | 2014 | 160 | |
| 5 | 2013 | 159 | |
| 6 | 2015 | 122 | |
| 7 | 2013 | 122 | |
| 8 | 2016 | 113 | |
| 9 | 2016 | 87 | |
| 10 | 2014 | 85 | |
| 11 | 2018 | 83 | |
| 12 | 2016 | 81 | |
| 13 | 2013 | 72 | |
| 14 | 2018 | 72 | |
| 15 | 2015 | 62 | |
| 16 | 2014 | 60 | |
| 17 | 2015 | 58 | |
| 18 | 2015 | 53 | |
| 19 | 2016 | 52 | |
| 20 | 2016 | 49 |
About David Lorente
David Lorente is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 100 papers that have together received 2.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (63 papers), Radiopharmaceutical Chemistry and Applications (26 papers), Cancer, Lipids, and Metabolism (18 papers), Cancer Genomics and Diagnostics (12 papers), PARP inhibition in cancer therapy (12 papers), Prostate Cancer Diagnosis and Treatment (11 papers), Cancer Treatment and Pharmacology (9 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Cancer Research (1.1k citations), Pulmonary and Respiratory Medicine (1.8k citations), Oncology (1.2k citations), Radiology, Nuclear Medicine and Imaging (653 citations) and Hematology (200 citations). David Lorente has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Johann S. de Bono, Aurelius Omlin, Gerhardt Attard, Joaquı́n Mateo, Roberta Ferraldeschi, Diletta Bianchini, David Olmos, Carmel Pezaro, Zafeiris Zafeiriou and Raquel Pérez-López. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Urology, British Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.